Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics
作者： Saumya Pant , Russell Weiner , Matthew J. Marton
关键词:
摘要: … Recent results from clinical studies support the emerging concept of the “mutation signature” or spectrum of correlated mutations in cancer (20, 21), which postulates that …
frontiersin.org
core.ac.uk
sci-hub.se 参考文章(124)
James O Westgard, Lawrence J Crolla, Evaluation of rule-based autoverification protocols. Clinical leadership & management review : the journal of CLMA. ,vol. 17, pp. 268- 272 ,(2003)
Richard W Tothill, Maria A Doyle, Cliff Meldrum, Next-Generation Sequencing for Cancer Diagnostics: a Practical Perspective The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 32, pp. 177- 195 ,(2011)
Thomas M. Sadtler, Rudy Ruggles, Heiner Baumann, Clayton M. Christensen, Disruptive innovation for social change. Harvard Business Review. ,vol. 84, pp. 94- 101 ,(2006)
Ahmad Awada, Philippe Barthelemy, Philippe G Aftimos, Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine. Discovery Medicine. ,vol. 17, pp. 81- 91 ,(2014)
Bob Carlson, In Search of the Perfect Business Model: As personalized medicine moves into the mainstream, makers of diagnostics must face a new economic reality. How to develop a value proposition in a healthcare market that is becoming increasingly elastic? Biotechnology healthcare. ,vol. 9, pp. 20- 23 ,(2012)
Iris Schrijver, Nazneen Aziz, Daniel H. Farkas, Manohar Furtado, Andrea Ferreira Gonzalez, Timothy C. Greiner, Wayne W. Grody, Tina Hambuch, Lisa Kalman, Jeffrey A. Kant, Roger D. Klein, Debra G.B. Leonard, Ira M. Lubin, Rong Mao, Narasimhan Nagan, Victoria M. Pratt, Mark E. Sobel, Karl V. Voelkerding, Jane S. Gibson, Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics. ,vol. 14, pp. 525- 540 ,(2012) , 10.1016/J.JMOLDX.2012.04.006
H Duzkale, J Shen, H McLaughlin, A Alfares, MA Kelly, TJ Pugh, BH Funke, HL Rehm, MS Lebo, A systematic approach to assessing the clinical significance of genetic variants. Clinical Genetics. ,vol. 84, pp. 453- 463 ,(2013) , 10.1111/CGE.12257
Geneva Young, Kai Wang, Jie He, Geoff Otto, Matthew Hawryluk, Zac Zwirco, Tina Brennan, Michelle Nahas, Amy Donahue, Roman Yelensky, Doron Lipson, Christine E. Sheehan, Ann B. Boguniewicz, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms. Cancer Cytopathology. ,vol. 121, pp. 688- 694 ,(2013) , 10.1002/CNCY.21338
Bob Carlson, Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trials. Biotechnology healthcare. ,vol. 9, pp. 21- 25 ,(2012)
Eline M. Bunnik, Antina de Jong, Niels Nijsingh, Guido M.W.R. de Wert, The New Genetics and Informed Consent: Differentiating Choice to Preserve Autonomy Bioethics. ,vol. 27, pp. 348- 355 ,(2013) , 10.1111/BIOE.12030